Aceclofenac in pharma franchise in Jabalpur

Aceclofenac in PCD pharma franchise in Indore

Aceclofenac in top pharma company In Thane

Aceclofenac in pcd pharma supplier in Bhopal

Aceclofenac SR in phama franchise company in India
Aceclofenac SR in phama distributor in Meerut

Home/Products /aceclofenac-200mg-tablet

Aceflick 200 SR Tablet

Composition : Aceclofenac (200mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹88/-

Aceflick 200 SR Tablet is a sustained-release formulation of Aceclofenac, a potent non-steroidal anti-inflammatory drug (NSAID) used for the effective management of pain and inflammation. The sustained-release mechanism ensures a prolonged therapeutic effect, reducing the need for frequent dosing and enhancing patient compliance.

Aceclofenac works by inhibiting cyclooxygenase (COX) enzymes, which play a crucial role in the production of prostaglandins—chemicals responsible for triggering pain, swelling, and inflammation in the body. By suppressing prostaglandin synthesis, Aceflick 200 SR Tablet provides relief in various chronic inflammatory conditions.

This medication is commonly prescribed for the treatment of musculoskeletal disorders, including osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Additionally, it is beneficial in managing soft tissue injuries and post-operative pain.

Read More

About the Product

Aceflick 200 SR Tablet is a sustained-release formulation of Aceclofenac, a potent non-steroidal anti-inflammatory drug (NSAID) used for the effective management of pain and inflammation. The sustained-release mechanism ensures a prolonged therapeutic effect, reducing the need for frequent dosing and enhancing patient compliance.

Aceclofenac works by inhibiting cyclooxygenase (COX) enzymes, which play a crucial role in the production of prostaglandins—chemicals responsible for triggering pain, swelling, and inflammation in the body. By suppressing prostaglandin synthesis, Aceflick 200 SR Tablet provides relief in various chronic inflammatory conditions.

This medication is commonly prescribed for the treatment of musculoskeletal disorders, including osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Additionally, it is beneficial in managing soft tissue injuries and post-operative pain.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Aceflick 200 SR Tablet alleviates pain and inflammation from rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis.

Information regarding the use of Aceflick 200 SR Tablet during breastfeeding is not available. Please consult your doctor.

Store in a cool, dry place away from sunlight.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation